You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -625.1% | -67.9% |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -29.5 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 45.8 | 6.4 |
| Price / Book value | 2.6 |
| Latest | Forecast | |
|---|---|---|
| Revenue | -46.4% | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 0.0% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | 0.17 | -4.40 | -62.00p | -11.5 | 0.0 | n/a | n/a | 0.0% |
| 2018-12-31 | 0.24 | -4.07 | -48.00p | -1.4 | 0.0 | n/a | n/a | 0.0% |
| 2019-12-31 | 0.74 | -3.63 | -43.00p | -1.6 | 0.0 | n/a | n/a | 0.0% |
| 2020-12-31 | 0.39 | -2.38 | -2.90p | -16.0 | 0.0 | n/a | n/a | 0.0% |
| NetScientific subsidiary strikes exclusive licensing deal with AstraZeneca Sharecast News | 07 Jun |
|---|
| Holding(s) in Company | 18-Jan-22 07:00 |
|---|---|
| PDS Granted Novel HPV16 Immunotherapy Patent | 10-Jan-22 14:20 |
| ProAxsis CEO End of Year Update | 10-Jan-22 07:00 |
| Issue of Equity | 29-Dec-21 08:48 |
| TR-1: Form for notification of major holdings | 21-Dec-21 13:59 |